This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharmacies and Pharmacy Benefit Managers. Those who preorder will receive a download link before March 18. On March 18, 2025, Drug Channels Institute will release The 2025 Economic Report on U.S. This reportour sixteenth editionremains the most comprehensive, fact-based tool for understanding the entire U.S.
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) HMP Global’s Drug Channels Institute releases ‘2024 Economic Report on U.S. The 2024 Economic Report on U.S.
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Analyzes Impact of Inflation Reduction Act on U.S.
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Examines Consolidation and Vertical Integration of U.S. Click to Enlarge].
Pharmacies and Pharmacy Benefit Managers. Those who preorder will receive a download link before March 15. CLICK HERE to download a free pre-publication overview. This 2022 edition addresses COVID-19 and its ongoing impact on the pharmacy and PBM industries. Download a free report overview for more details.
Pharmacies and Pharmacy Benefit Managers. Those who preorder will receive a download link before March 14. CLICK HERE to download a free pre-publication overview (including key industry trends, the Table of Contents, and a List of Exhibits). Download a free report overview for more details on the new sections and content.
Pharmacies and Pharmacy Benefit Managers. Those who preorder will receive a download link before March 19. Download a free pre-publication overview (including key industry trends, the Table of Contents, and a List of Exhibits). On March 19, 2024, Drug Channels Institute will release The 2024 Economic Report on U.S.
Pharmacies and Pharmacy Benefit Managers. The largest 15 pharmacies accounted for more than 75% of total dispensing revenues from retail, mail, long-term care, and specialty pharmacies. How will GoodRx and Mark Cuban Cost Plus Drug Company affect the pharmacy industry? to 1:30 p.m. to 1:30 p.m.
Pharmacies and Pharmacy Benefit Managers. The total share of the largest 15 companies decreased slightly compared with their 2020 share, due primarily to below-market growth rates at retail and long-term care pharmacies. Read on as we cue up our latest update on the booming pharmacy and PBM marketplace.
Pharmacies and Pharmacy Benefit Managers. For a sneak peek at the complete report, click here to download our free report overview (including key industry trends, the table of contents, and a list of exhibits). How will the most consequential change in federal drug pricing policy affect the largest pharmacies and PBMs?
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook This event will be broadcast live on Friday, March 31, 2023, from 12:00 p.m. Pharmacies and Pharmacy Benefit Managers.
for an exclusive deep dive into the latest trends, data, and strategies shaping the pharmacy benefit management (PBM) industry. Pharmacies and Pharmacy Benefit Managers , Dr. Fein will provide invaluable insights to help you and your team stay informed about this rapidly evolving market. Fein, Ph.D.,
Informa Connect’s Hub and Specialty Pharmacy Models East. June 28-30, 2022 | Sheraton Parsippany | Parsippany, NJ www.informaconnect.com/hub-specialty-pharmacy. For 2022 only, Hub and Specialty Pharmacy Models and PAP – Patient Assistance & Access Programs are under the same roof. Delivered as a Hybrid Event.
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: The Latest Trends for U.S. The 2021 Economic Report on U.S.
To learn more, download the whitepaper: The Kalderos 340B Rebate Model In Action: Ensuring a Thriving and Sustainable 340B Program. Jeremy describes Kalderos’ 340B rebate model. He discusses an independent research organization’s study of the 340B rebate model’s impact on covered entities’ cash flow. Read on for Jeremy’s insights.
Pharmacies and Pharmacy Benefit Managers. Those who preorder will receive a download link before March 16. CLICK HERE to download a free pre-publication overview. On March 16, 2021, Drug Channels Institute will release The 2021 Economic Report on U.S. drug pricing, reimbursement, and dispensing system.
Informa Connect’s Trade and Channel Strategies December 10-12, 2024 at the W Hotel in Philadelphia, PA Drug Channels readers save 10% with code 24DC10 * Pharmacy and distribution models are growing increasingly complex. Is my organization haemorrhaging money to stay afloat with the shift to alternative distribution and pharmacy models?
Today’s guest post comes from Megan Marchal, Director of Specialty Pharmacy Strategy at CoverMyMeds. Learn more about CoverMyMeds’ patient-centric technology solutions by downloading their Access Report: Oncology Edition. Megan discusses upcoming specialty medication launches.
Today’s guest post comes from Michael Carr, Group Vice President, CoAssist Pharmacy at AssistRx. To learn about AssistRx’s digital intake technologies, download their case study: Digital Intake for More Meaningful Patient and HCP Interactions. He outlines four key features of solutions that improve digital intake.
In Preferred Pharmacy Networks in 2023’s Medicare Part D Plans: Cigna, CVS Health, Humana, UnitedHealthcare, WellCare, and More , I highlighted how those networks have taken over the world of stand-alone Medicare Part D prescription drug plans (PDP) and become a major presence in Medicare Advantage prescription drug (MA-PD) plans.
He then describes how ConnectiveRx’s non-commercial pharmacy solution streamlines workflow for healthcare providers and captures useful data for brands. Click here to download a free information sheet about the ConnectiveRx Careform non-commercial pharmacy. Read on for Frank’s insights. d/b/a Drug Channels Institute.
In this article, Kristina reviews how brands can help patients make connections that address medication affordability challenges, whether at the prescriber’s office, the pharmacy, or at home. Read on for Kristina’s insights.
In this article, Kristina reviews how brands can help patients make connections that address medication affordability challenges, whether at the prescriber’s office, the pharmacy, or at home. Read on for Kristina’s insights.
After the event, every registrant will receive a link to download the complete slide deck and have an opportunity to watch a replay of the live event. Fein will give participants an opportunity to unmute themselves and ask live questions. The webinar will last 90 minutes to accommodate audience questions. d/b/a Drug Channels Institute.
Another surprise: HRSA estimated that manufacturers' contract pharmacy restrictions reduced 340B purchases by only $470 million—or less than 1% of 2022's total purchases. Read on for full details and analysis, including the opportunity to download your own copy of the raw data from HRSA. As I noted last year, only in the U.S.
Pharmacies and Pharmacy Benefit Managers. Or, download this spreadsheet and email your registrants’ information to Tamra Feldman ( admin@drugchannels.net ). We recommend that every registrant download the Zoom client software/app. He will draw from exclusive information found in DCI's 2023 Economic Report on U.S.
Another surprise: HRSA estimated that manufacturers' contract pharmacy restrictions reduced 340B purchases by only $470 million—or less than 1% of 2022's total purchases. Read on for full details and analysis, including the opportunity to download your own copy of the raw data from HRSA. As I noted last year, only in the U.S.
Ashleigh explains how biopharma companies can help patients become more adherent and achieve better health outcomes by partnering with an experienced specialty pharmacy that offers risk-based care. . To learn more about the risk-based care approach, download the free whitepaper: Risk-Based Care Helps Cancer Treatment Adherence.
A program driven by market dynamics and led by champions of channel strategy, join now to master the complexities of pharmacy and distribution models to accelerate market access –It's all happening December 11-13, 2023. What can you expect?
Join your industry counterparts this December to unravel the complexities of the channel, navigate high-impact topics transforming trade and benchmark winning pharmacy and distribution frameworks. Drug Channels readers will save 10% off the current registration rate when they use promo code 10DC21*. Meet The Expert Faculty.
Pharmacies and Pharmacy Benefit Managers. The exhibit below—one of 203 in our new report—provides a first look at the 15 largest pharmacies, ranked by total U.S. As you will see, pharmacy industry prescription dispensing revenues reached a record $446 billion in 2019.
Pharmacies and Pharmacy Benefit Managers. The exhibit below—one of 203 in our new report—provides a first look at the 15 largest pharmacies, ranked by total U.S. As you will see, pharmacy industry prescription dispensing revenues reached a record $446 billion in 2019.
Pharmacies and Pharmacy Benefit Managers. The largest players all had bigger slices of the revenue pie, due to the growth at specialty pharmacies and multiple transactions that shifted market share among the vertically integrated companies. Click here to see the original post and comments from March 2021.
Pharmacies and Pharmacy Benefit Managers. The largest players all had bigger slices of the revenue pie, due to the growth at specialty pharmacies and multiple transactions that shifted market share among the vertically integrated companies. Next week, Drug Channels Institute will release our 2021 Economic Report on U.S.
I am pleased to announce our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. If you preordered the report, you should have already received an email with download instructions. Section 6.1.5. Please contact us if you did not receive the email.
I am pleased to announce our new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. Click here to download a free report overview (including a summary of industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: U.S.
You can download the complete agenda here. Visit www.informaconnect.com/trade-channel for further details and to register. Drug Channels readers will save $200 off the standard rate when they use code KTP933 and register prior to November 20th.*. Stuart Parker, Senior Director, Trade Relations, Mayne Pharma And more!
You can download the complete agenda here. Download the agenda to plan your sessions and wrap up your week armed with critical updates and valuable takeaways. Visit www.informaconnect.com/trade-channel for further details and to register.
Download your FREE copy today. Immerse yourself in exclusive content, including articles on cutting-edge cell line development and insightful interviews with industry experts. Don’t miss your chance to embrace the future of cellular therapies – dive in now! This eBook is supported by BioTechne.
Read on for full details and analysis, including the opportunity to download your very own copy of the raw data from HRSA. This figure approximates the money collected by 340B covered entities. 340B advocates have been screaming that “drug companies are cutting 340B,” but the data tell a very different story. Only in the U.S.
Once again, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have increased the number of drugs they have excluded from their standard formularies. . The 2021 formulary exclusion lists are available below for your downloading pleasure.
Once again, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have increased the number of drugs they have excluded from their standard formularies. . The 2021 formulary exclusion lists are available below for your downloading pleasure.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content